Security National Bank Increases Stock Position in Zoetis Inc. (NYSE:ZTS)

Security National Bank increased its holdings in Zoetis Inc. (NYSE:ZTS - Free Report) by 4.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 50,040 shares of the company's stock after acquiring an additional 2,145 shares during the quarter. Zoetis makes up about 1.6% of Security National Bank's holdings, making the stock its 16th biggest position. Security National Bank's holdings in Zoetis were worth $8,239,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the business. Brighton Jones LLC raised its stake in Zoetis by 180.4% during the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company's stock valued at $754,000 after acquiring an additional 2,978 shares during the last quarter. Bank Pictet & Cie Europe AG increased its holdings in shares of Zoetis by 5.4% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 419,530 shares of the company's stock valued at $68,354,000 after purchasing an additional 21,470 shares during the period. Sigma Planning Corp increased its holdings in shares of Zoetis by 4.3% in the fourth quarter. Sigma Planning Corp now owns 3,367 shares of the company's stock valued at $549,000 after purchasing an additional 140 shares during the period. IFP Advisors Inc raised its stake in shares of Zoetis by 13.0% during the fourth quarter. IFP Advisors Inc now owns 10,033 shares of the company's stock worth $1,635,000 after purchasing an additional 1,158 shares during the last quarter. Finally, Lake Street Advisors Group LLC raised its stake in shares of Zoetis by 3.1% during the fourth quarter. Lake Street Advisors Group LLC now owns 11,186 shares of the company's stock worth $1,823,000 after purchasing an additional 341 shares during the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Zoetis

In other news, EVP Roxanne Lagano sold 652 shares of the company's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total value of $110,840.00. Following the sale, the executive vice president now directly owns 15,129 shares in the company, valued at $2,571,930. This represents a 4.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.18% of the stock is currently owned by insiders.

Zoetis Price Performance

Shares of NYSE ZTS traded down $1.22 during midday trading on Thursday, hitting $156.01. The company had a trading volume of 3,122,696 shares, compared to its average volume of 2,569,289. The firm has a market capitalization of $69.46 billion, a price-to-earnings ratio of 28.01, a price-to-earnings-growth ratio of 2.62 and a beta of 0.94. Zoetis Inc. has a twelve month low of $139.70 and a twelve month high of $200.33. The business has a 50-day simple moving average of $160.10 and a two-hundred day simple moving average of $163.02. The company has a quick ratio of 1.04, a current ratio of 1.74 and a debt-to-equity ratio of 1.12.

Zoetis (NYSE:ZTS - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.40 by $0.08. Zoetis had a net margin of 27.12% and a return on equity of 55.48%. The company had revenue of $2.22 billion during the quarter, compared to analysts' expectations of $2.20 billion. During the same period last year, the company posted $1.38 earnings per share. The firm's quarterly revenue was up 1.4% compared to the same quarter last year. Equities research analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, July 18th. This represents a $2.00 annualized dividend and a yield of 1.28%. Zoetis's dividend payout ratio (DPR) is currently 35.91%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on ZTS. Wall Street Zen raised shares of Zoetis from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Stifel Nicolaus downgraded shares of Zoetis from a "buy" rating to a "hold" rating and lowered their target price for the company from $165.00 to $160.00 in a report on Wednesday, June 18th. UBS Group dropped their price target on shares of Zoetis from $189.00 to $170.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 7th. Finally, Piper Sandler increased their price target on shares of Zoetis from $205.00 to $210.00 and gave the stock an "overweight" rating in a report on Monday, May 12th. Two analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $212.13.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.